The relationship between comorbidity medication adherence and health related quality of life among patients with cancer.

Conclusion: The positive association between low comorbidity medication adherence and the number of unhealthy days suggests that addressing barriers to comorbidity medication adherence during cancer treatment may be an avenue for improving or maintaining HRQoL for older patients with cancer and comorbid conditions. PMID: 30294709 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/30294709?dopt=Abstract

Source: Cancer Control - October 9, 2018 Category: Cancer & Oncology Authors: Drzayich Antol D, Waldman Casebeer A, Khoury R, Michael T, Renda A, Hopson S, Parikh A, Stein A, Costantino M, Stemkowski S, Bunce M Tags: J Patient Rep Outcomes Source Type: research